KLF4 inhibits DYRK2 gene expression by binding to the endogenous DYRK2 promoter and plays a role in maintaining c-Myc expression in CML stem/progenitor cells [12]. The gene discussed is KLF4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.